GRDN
Guardian Pharmacy Services, Inc.
NYSE Healthcare United States
41,87 $US
+4.31% today
+41.79% YTD · +54.79% 1Y
17
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
5
Hedge funds tracked
Latest available SEC 13F filings
65
/ 100
STRONG

Analysis Guardian Pharmacy Services, Inc. (GRDN) — Kairos Score 65/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Key info

👔
CEO
Mr. Fred P. Burke
📍
HQ
300 Galleria Parkway SE, Suite 800, Atlanta, GA, 30339, United States
👥
Employees
3 600
💰
Market cap
2 652 142 080,00 $US
📊
P/E
40.7
💸
Dividend yield
0.00%

🕴️ Insider activity (90 days)

17 transactions — 0 buys and 0 sales reported by Guardian Pharmacy Services, Inc. executives.

MW
Mudd William Franklin
See Remarks · 2026-09-27
Other
WR
Weir Robert
See Remarks · 2026-09-27
Other
AJ
Ackerman John
2026-09-27
Other

🏦 Hedge Funds

5 institutional funds report a position on GRDN in their latest SEC quarterly filing.

DRIEHAUS CAPITAL MANAGEMENT LLC
Clearbridge Investments, LLC
Russell Investments Group, Ltd.
LOS ANGELES CAPITAL MANAGEMENT LLC
BNP PARIBAS FINANCIAL MARKETS

📰 Recent news

15 recent articles on GRDN.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Guardian Pharmacy Services, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of GRDN on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 17 insider transactions over 90 days
✅ All 5 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year